Article
Programming gene and engineered-cell therapies with synthetic biology
9 Feb 2018
Abstract excerpt
Gene and engineered-cell therapies promise to treat diseases by genetically modifying cells to carry out therapeutic tasks. Although the field has had some success in treating monogenic disorders and hematological malignancies, current approaches are limited to overexpression of one or a few transgenes, constraining the diseases that can be treated with this approach and leading to potential concerns over safety...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
